“Soon we can meet again IRL”

The Flemingsberg Science Foundation turns ten this year. Ten years of entrepreneurship, campus development and regional collaboration.

How well we have succeeded is up to others to assess, and so we have initiated an evaluation of the foundation’s work to date, which will also give an impetus for the choice of future strategies and implementation models. The evaluation is expected to be completed in late autumn, just in time for the change of Foundation CEO when I retire in November. More on that later.

Since the Covid outbreak, our work has been characterised by video meetings, especially in our various focus groups. Success has exceeded expectations, thanks to the fact that the approximately 70 people who are involved in the groups had time to get to know one other and the issues even before the pandemic. But we are really looking forward to being able to meet again IRL, and hopefully soon – it is so much more enjoyable!

Many planned projects that were cancelled, such as the campus day and business club, etc., can now return and be included in planning for future activities. One project that has gone well despite the pandemic is the Stockholm Life Tech regional collaboration, which aims to open up public development resources for companies. Here, our advanced cell laboratories in Flemingsberg play a central role, and extensive work is underway to be able to involve more companies in the development of advanced therapies. In the long run, this can also form the basis for a growing industrial cluster in Flemingsberg.

Other very pleasing subjects are that our classic development area Healthy Ageing has received a fresh start and very considerable support from universities, healthcare organisations and companies to develop common solutions for this major societal challenge. Also there is a growing insight into the cultural sector’s potential to collaborate with other areas of knowledge, contributing with creative working methods and new perspectives.

There is a lot here to do!

Björn Varnestig, VD Flemingsberg Science

NextCell to treat type 1 diabetes in children with stem cells

NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.

Flemingsberg middle school students learn all about coding

The “Kodkuporna” programme started in Flemingsberg in May, a project that gives children and young people the opportunity to try their hand at programming. Students from KTH and Södertörn University mentor middle school students from Vistaskolan in play-based learning.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

CF_logo_neg
2021-09-09T09:38:43+02:00
Go to Top